PROCTER & GAMBLE HEALTH L (PGHL.NS) Financials
PGHL.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 10.8 billion | 2.7 billion |
| 2023-09-30 | ? | ? |
| 2023-06-30 | 11.0 billion | 3.5 billion |
| 2023-03-31 | ? | ? |
PGHL.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | ? | ? |
| 2023-06-30 | ? | ? |
| 2023-03-31 | ? | ? |
PGHL.NS Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 720.7 million |
| 2023-09-30 | 655.7 million |
| 2023-06-30 | 298.2 million |
| 2023-03-31 | 591.9 million |
PGHL.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | 108.0 million |
| 2023-09-30 | - | - | - |
| 2023-06-30 | 4.5 billion | 88.8 million | 120.0 million |
| 2023-03-31 | - | - | - |
PGHL.NS Shares Outstanding
PGHL.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | - | - | 606.4 million | - |
| 2023-06-30 | 424.8 million | - | 554.0 million | - |
| 2023-03-31 | - | - | 607.3 million | - |
PGHL.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 3.1 billion | 903.9 million |
| 2023-09-30 | 3.0 billion | 871.4 million |
| 2023-06-30 | 3.0 billion | 938.7 million |
| 2023-03-31 | 3.2 billion | 1.0 billion |
PGHL.NS
Price: ₹4,792.50
Dividend Yield: 0.02%
Forward Dividend Yield: 2.09%
Payout Ratio: 73.27%
Dividend Per Share: 100.00 INR
Earnings Per Share: 136.49 INR
P/E Ratio: 38.78
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 77.4 billion
Average Dividend Frequency: 1
Years Paying Dividends: 11
DGR3: 27.47%
DGR5: 30.00%